Jamie Udasin (Née Mathew)
About Jamie Udasin (Née Mathew)
Jamie Udasin is the Worldwide Medical Director for Cendakimab at Bristol Myers Squibb, specializing in eosinophilic gastrointestinal diseases. She has extensive experience in pediatric gastroenterology and holds an MD from New York Medical College.
Company
Jamie Udasin currently works at Bristol Myers Squibb in Lawrence, New Jersey, United States. She holds the position of Worldwide Medical Director, Cendakimab. In this role, she guides the worldwide medical strategy for cendakimab, which specifically targets eosinophilic gastrointestinal diseases (EGIDs).
Title
Jamie Udasin serves as the Worldwide Medical Director, Cendakimab at Bristol Myers Squibb. Her responsibilities include leading global medical strategies for the drug, with a specialized focus on eosinophilic gastrointestinal diseases (EGIDs).
Education and Expertise
Jamie Udasin holds multiple advanced degrees from prestigious institutions. She earned her Doctor of Medicine (MD) and a Master of Science (M.S.) in Basic Medical Science from New York Medical College. Additionally, she obtained a Bachelor of Arts (B.A.) in Psychology from the University of Pennsylvania. She is board certified in both Pediatrics and Pediatric Gastroenterology, underscoring her specialized expertise in medical sciences.
Background
Jamie Udasin has an extensive background in pediatric gastroenterology and medical research. She completed a Fellowship in Pediatric Gastroenterology at Children's Hospital at Montefiore from 2018 to 2021. Prior to that, she served as a Resident Physician at the same hospital from 2015 to 2018. She also worked as a Research Assistant in the Department of Physiology at New York Medical College from 2009 to 2012.